The stock of Cosmos Health Inc. (NASDAQ:COSM) increased by $0.03 on Friday to finish at $1.32, up 2.33 percent. The last five days have seen an average of 1,484,940 shares of common stock traded. 5 times new highs were reached in the current year, with a fall of -$3.2400. The average number of shares traded over the last 20 days was 1,055,460, while the average volume over the last 50 days totaled 630,550.
COSM stock dropped -60.60% since last month. On 08/07/23, the company’s shares reached a one-month low of $1.1100. The stock touched a high of $23.84 on 01/26/23, after rallying from a low of $1.11 in 52 weeks. The price of COSM stock has declined by -71.05% or -$3.2400 this year, reaching a new high 5 times. Still, the stock price is down -94.46% from the 52-week high.
Insider Transactions
COSM stock investors should be aware that Cosmos Health Inc. (COSM) stock had its last reported insider trading activity 25 days ago on Jul 20. On Jul 20, Chief Executive Officer Siokas Grigorios acquired 181,451 shares at $2.48 each. This transaction resulted in the insider spending $449,998. On Jun 06, Siokas Grigorios added 4,474 shares at a price of US$23.92. After the transaction, the insider now owns 1,146,434 shares. Chief Executive Officer Siokas Grigorios had earlier bought 4,474 shares on Apr 27 for $24.64 a share. The transaction was completed for $110,239.
Valuation Metrics
Beta for the stock is 3.01. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.34, the price-to-book (PB) ratio of 0.32.
Financial Health
For the recent quarter, Cosmos Health Inc.’s quick ratio was 2.50, while its current ratio was 2.70, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the recent quarter is 0.07, and the total debt to equity ratio is 0.20. As far as profitability goes, gross margin for the trailing twelve months is 10.10% percent. Cosmos Health Inc.’s EBITDA margin for the recent year was -14.47%, whereas its operating margin stood at -17.40% for the same period. Based on annual data, it had gross profit of $5.96 million and revenue of $50.35 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. COSM’s return on assets (ROA) during the last 12 months has been -102.50%. There was a -14.30% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -256.10%.
Earnings Surprise
A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $12.35 million, while revenues fell by -5.83% to $12.05 million. EBITDA was -$2.55 million for the quarter. At the end of Cosmos Health Inc.’s most recent quarter, its liabilities totaled 24.01 million, while its total debt was $9.76 million. Equity owned by shareholders amounts to $10.62 million.
Technical Picture
Here’s a quick look at Cosmos Health Inc.’s (COSM) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 34.62%, suggesting the stock is Neutral, with a 165.22% historical volatility rate.
The stochastic %K and %D were 17.89% and 16.79% respectively, while the average true range (ATR) was 0.2231. Based on the 14-day stochastic reading of 26.94%, the RSI (14) reading is 31.23%. On the 9-day MACD Oscillator, the stock is at -0.0367, and the 14-day reading is at -0.1462.
Analyst Ratings
Analysts have assigned Cosmos Health Inc. (COSM) an – rating. COSM is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
